FinnProstate Group

The FinnProstate Group (FP), or FinnProstate Study Group, is a group of scientific researchers in Finland who have conducted a series of clinical trials of treatments for prostate cancer.[1] The first publication by the group was in 1985[2] and the latest publication was in 2019.[3]

  1. ^ Emmans Dean M, Norman G, Hodges Z, Ritchie G, Light K, Eastwood A, Langley R, Sydes M, Parmar M, Abel P (2006), Parenteral Oestrogens for Prostate Cancer: A Systematic Review of Clinical Effectiveness and Dose Response (CRD Report 33) (PDF), York: Centre for Reviews and Dissemination/University of York/York Publishing Services, ISBN 1900640376, archived from the original (PDF) on 2021-09-08
  2. ^ Haapiainen R, Rannikko S, Ruutu M, Ala-Opas M, Aro J, Ervasti J, Hansson E, Hurme K, Juusela H, Mäkinen J (1985). "Early results of the Finnish Multicentre Study of Prostatic Cancer (Finnprostate)". Ann Chir Gynaecol. 74 (6): 277–83. PMID 4096480.
  3. ^ Hackman G, Taari K, Tammela TL, Matikainen M, Kouri M, Joensuu T, Luukkaala T, Salonen A, Isotalo T, Pétas A, Hendolin N, Boström PJ, Aaltomaa S, Lehtoranta K, Hellström P, Riikonen J, Korpela M, Minn H, Kellokumpu-Lehtinen PL, Pukkala E, Hemminki A (November 2019). "Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension". Eur Urol. 76 (5): 586–595. doi:10.1016/j.eururo.2019.07.001. hdl:10138/306830. PMID 31375279. S2CID 199389424.